News | RIVM

People living in small-scale residential facilities vaccinated sooner by deploying Moderna as well as Pfizer/BioNTech

Starting next week, vaccination for clients receiving care under the Long-Term Care Act, who are living in small-scale residential facilities without an institutional physician, will be expanded to the Pfizer/BioNTech vaccine and Moderna vaccine.

Man receives COVID-19 vaccination at GGD vaccination site

Lareb notes newly reported deaths shortly after vaccination

The Pharmacovigilance Centre Lareb announced today that the centre had received a total of 15 reports so far regarding deaths shortly after receiving the COVID-19 vaccinations.

New research in GGD test lanes on spread of coronavirus SARS-CoV-2

RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.

80 to 84-year-olds invited for vaccination sooner

Starting tomorrow, the first people in the age group from 80-84 years in the Netherlands will receive an invitation from RIVM for a COVID-19 vaccination.

New variants disrupt plans

In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.

One person died shortly after COVID-19 vaccination

The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.

Nationwide assessment of SARS-CoV-2 laboratories: very high quality

The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.